ConforMIS iTotal CR
-
Recon
Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR
BILLERICA, Mass., March 07, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed…
Read More » -
Recon
ConforMIS Announces Positive Results from Clinical Studies Comparing the ConforMIS iTotal® CR to Leading “Off-The-Shelf” Total Knee Replacement Products
BEDFORD, Mass., March 30, 2016 (GLOBE NEWSWIRE) — ConforMIS, Inc., a medical technology company that offers joint replacement implants customized…
Read More »